Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.
Joakim NordanstigStefan JamesManne AnderssonMattias AnderssonPeter DanielssonPeter GillgrenMartin DelleJan EngströmTorbjörn FranssonMaher HamoudAnna HilbertsonPatrik JohanssonLars KarlssonBjörn KragstermanHans LindgrenKarin LudwigsStefan MellanderNiklas NymanHenrik RenlundBirgitta SigvantPer SkoogJoachim StarckGustaf TeglerAsko ToivolaMaria TruedsonCarl-Magnus WahlgrenJonas WallinderAndreas ÖjersjöMårten FalkenbergPublished in: The New England journal of medicine (2020)
In this randomized trial in which patients with peripheral artery disease received treatment with paclitaxel-coated or uncoated endovascular devices, the results of an unplanned interim analysis of all-cause mortality did not show a difference between the groups in the incidence of death during 1 to 4 years of follow-up. (Funded by the Swedish Research Council and others; ClinicalTrials.gov number, NCT02051088.).